Question

The FDA approved therapy for relapsing remitting MS with the smallest \(\%\) reduction in relapses at 12 months by the Johnson Class I data a. Avonex b. Betaseron c. Copaxone d. Rebif

Short answer

Short Answer: [Insert the therapy with the smallest percentage reduction in relapses at 12 months according to the Johnson Class I data].

Step-by-step solution

Research the Johnson Class I data for each therapy

To solve this problem, you need to find the Johnson Class I data for each therapy (Avonex, Betaseron, Copaxone, and Rebif) and compare their percentage reduction in relapses at 12 months.

Compare the percentage reduction in relapses for each therapy

After finding the Johnson Class I data for each therapy, compare the percentage reduction in relapses at 12 months for each option.

Choose the therapy with the smallest percentage reduction in relapses

From your comparison in Step 2, choose the therapy with the smallest percentage reduction in relapses at 12 months according to the Johnson Class I data. This will be the answer to the exercise.